top of page

Canada Launches First-Ever Clinical Guidelines on Substance Use Disorders in Older Adults

Updated: Feb 6, 2020

As clinicians and community-based individuals, we encounter problematic substance use as well as Substance Use Disorder among older adults in our daily work. Canadian healthcare providers now have the tools they need to better support the prevention, assessment and treatment of older adults at risk of, or living with, substance use disorders.

The Canadian Coalition for Seniors’ Mental Health (CCSMH) officially launched 4 sets of Clinical Guidelines on Substance Use Disorders in Older Adults on January 20th, 2020. The project was funded by Health Canada. These Clinical Guidelines on the prevention, screening, assessment and treatment of Alcohol, Cannabis, Benzodiazepine and Opioid Use Disorders among older adults are available online at In addition to these Guidelines, the CCSMH will be producing community brochures and other knowledge translation material on substance use disorder among older adults in the coming months.

Key Messages from each Guideline Document

Alcohol Use Disorder Guidelines

Alcohol Use Disorder (AUD) and risky alcohol consumption is common among older adults, with problem drinking rates reported to be as high as 22%. 1–22% Older adults need and deserve a continuum of care for Alcohol Use Disorder (AUD) that matches the severity, life circumstance, concurrent mental and physical health issues, and social transitions which they are experiencing. Click here to read more about low risk drinking guidelines for older adults.

Benzodiazepine Receptor Agonist Use Disorder Guidelines

Benzodiazepine receptor agonists (BZRAs) are the most commonly prescribed psychiatric medication among all adults. Despite the wide agreement that BZRAs should be avoided whenever possible in older adults, these medications continue to be frequently prescribed. Click here to read more on a recommended BZRA tapering schedule.